Related Experiment Video
Updated: Jul 23, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Leading beyond regulatory approval: Opportunities for statisticians to optimize evidence generation and impact
Jenny Devenport1, Alexander Schacht2,
1Data Sciences, Hoffmann-La Roche Ltd, Basel, Basel Stadt, Switzerland.
Abstract:
The role and value of statistical contributions in drug development up to the point of health authority approval are well understood. But health authority approval is only a true 'win' if the evidence enables access and adoption into clinical practice. In today's complex and evolving healthcare environment, there is additional strategic evidence generation, communication, and decision support that can benefit from statistical contributions. In this article, we describe the history of medical affairs in the context of drug development, the factors driving post-approval evidence generation needs, and the opportunities for statisticians to optimize evidence generation for stakeholders beyond health authorities in order to ensure that new medicines reach appropriate patients.
More Related Videos
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
Statgraphics
Biostatistics: Overview
Discrete variables are...
Overview of Biostatistics in Health Sciences
Introduction to Epidemiology
Steps in Outbreak Investigation

